CAPENON

Table of contents:

The "CAPENON" trademark, serial number 79010689 , was filed on 8th of February 2005 with a mark drawing code of 5000 and its transaction date is 79010689. Since 19th of January 2012, the document can be found in the M40 law office in the publication and issue section. The employee responsible is AXILBUND, MELVIN T and the date it was published for opposition on 11/08/2005. The status of this trademark was checked last on 01/31/2006.

The "CAPENON" trademark, serial number 85499809 , was filed on 20th of December 2011 with a mark drawing code of 5000 and its transaction date is 85499809. Since 6th of July 2012, the document can be found in the M60 law office in the publication and issue section. The status of this trademark was checked last on 07/06/2012.

The corresponded responsible for this trademark is CHRISTOPHER S. ADKINS, located at WENDEROTH, LIND & PONACK, L.L.P, 1030 15TH ST NW STE 400, WASHINGTON, DC 20005-1503.

The state or country where the trademark was organized is by Daiichi Sankyo Company, Limited. The legal entity type behing it is a Joint Stock Company, located at 3-5-1, Nihonbashi Honcho, Chuo-ku, Tokyo, zip 103-8426.Other trademarks by this applicant: BENLOPINE, BENIRAL.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date01/03/2012
Primary Code005
Goods codes
CC0000Color is not claimed as a feature of the mark.
DM0000The mark consists of the stylized term "CAPENON".
GS0051Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease; vaccines; diagnostic reagents and contrast media for medical use
FOREGIN REGISTRATION
Foreign Registration Date10/14/2005
Foreign Expiration Date10/14/2015
Foreign Registration Number4901212
PROSECUTION HISTORY
DateDescriptionTypeCode
07/06/2012 TEAS/EMAIL CORRESPONDENCE ENTERED I - Incoming Correspondence TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2012 CORRESPONDENCE RECEIVED IN LAW OFFICE I - Incoming Correspondence CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2012 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
06/20/2012 TEAS RESPONSE TO OFFICE ACTION RECEIVED I - Incoming Correspondence TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2012 NON-FINAL ACTION MAILED F - First Action CNRT - NON-FINAL ACTION MAILED
01/20/2012 NON-FINAL ACTION WRITTEN R - Renewal CNRT - NON-FINAL ACTION WRITTEN
01/20/2012 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
01/03/2012 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
12/23/2011 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.